Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.19
(0.53%)
HKD 0.19
(0.53%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 914.37 Million HKD | -23.12% |
| 2022 | 1.18 Billion HKD | 26.83% |
| 2021 | 937.75 Million HKD | -4.55% |
| 2020 | 982.48 Million HKD | 28.11% |
| 2019 | 766.91 Million HKD | 10.74% |
| 2018 | 692.53 Million HKD | 27.72% |
| 2017 | 542.21 Million HKD | 30.52% |
| 2016 | 415.42 Million HKD | 10.68% |
| 2015 | 375.33 Million HKD | 129.19% |
| 2014 | 163.76 Million HKD | 216.87% |
| 2013 | -140.12 Million HKD | 57.97% |
| 2012 | -333.38 Million HKD | -109.68% |
| 2011 | -158.99 Million HKD | 28.47% |
| 2010 | -222.26 Million HKD | 35.43% |
| 2009 | -344.22 Million HKD | -364.76% |
| 2008 | -74.06 Million HKD | -111.01% |
| 2007 | 672.43 Million HKD | 9.9% |
| 2006 | 611.86 Million HKD | 10.62% |
| 2005 | 553.12 Million HKD | 9.62% |
| 2004 | 504.59 Million HKD | 8.58% |
| 2003 | 464.73 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 994.94 Million HKD | -4.39% |
| 2023 Q1 | 1.04 Billion HKD | -12.5% |
| 2023 FY | 914.37 Million HKD | -23.12% |
| 2023 Q4 | 914.37 Million HKD | -13.01% |
| 2023 Q3 | 1.05 Billion HKD | 5.65% |
| 2022 FY | 1.18 Billion HKD | 26.83% |
| 2022 Q3 | 1.23 Billion HKD | 17.14% |
| 2022 Q4 | 1.18 Billion HKD | -3.63% |
| 2022 Q2 | 1.05 Billion HKD | -4.0% |
| 2022 Q1 | 1.09 Billion HKD | 17.04% |
| 2021 Q1 | 907.96 Million HKD | -7.58% |
| 2021 Q2 | 862.14 Million HKD | -5.05% |
| 2021 Q3 | 981.63 Million HKD | 13.86% |
| 2021 Q4 | 937.75 Million HKD | -4.47% |
| 2021 FY | 937.75 Million HKD | -4.55% |
| 2020 FY | 982.48 Million HKD | 28.11% |
| 2020 Q4 | 982.48 Million HKD | -4.36% |
| 2020 Q2 | 863.95 Million HKD | -4.82% |
| 2020 Q3 | 1.02 Billion HKD | 18.9% |
| 2020 Q1 | 907.69 Million HKD | 18.36% |
| 2019 Q4 | 766.91 Million HKD | -5.38% |
| 2019 Q2 | 725.45 Million HKD | -6.79% |
| 2019 FY | 766.91 Million HKD | 10.74% |
| 2019 Q1 | 778.32 Million HKD | 12.39% |
| 2019 Q3 | 810.49 Million HKD | 11.72% |
| 2018 Q2 | 578.19 Million HKD | -14.18% |
| 2018 Q3 | 738.39 Million HKD | 27.71% |
| 2018 Q4 | 692.53 Million HKD | -6.21% |
| 2018 FY | 692.53 Million HKD | 27.72% |
| 2018 Q1 | 673.74 Million HKD | 24.26% |
| 2017 Q4 | 542.21 Million HKD | -10.8% |
| 2017 Q3 | 607.85 Million HKD | 27.6% |
| 2017 Q2 | 476.39 Million HKD | -12.11% |
| 2017 Q1 | 542.03 Million HKD | 30.48% |
| 2017 FY | 542.21 Million HKD | 30.52% |
| 2016 Q3 | 481.06 Million HKD | 45.27% |
| 2016 Q4 | 415.42 Million HKD | -13.64% |
| 2016 Q1 | 396.79 Million HKD | 5.72% |
| 2016 FY | 415.42 Million HKD | 10.68% |
| 2016 Q2 | 331.15 Million HKD | -16.54% |
| 2015 Q2 | 222.39 Million HKD | -22.79% |
| 2015 Q3 | 440.97 Million HKD | 98.28% |
| 2015 Q4 | 375.33 Million HKD | -14.89% |
| 2015 Q1 | 288.03 Million HKD | 75.88% |
| 2015 FY | 375.33 Million HKD | 129.19% |
| 2014 Q3 | 229.4 Million HKD | 124.66% |
| 2014 FY | 163.76 Million HKD | 216.87% |
| 2014 Q1 | 102.11 Million HKD | 172.88% |
| 2014 Q4 | 163.76 Million HKD | -28.61% |
| 2014 Q2 | 102.11 Million HKD | 0.0% |
| 2013 Q3 | -153.23 Million HKD | 0.0% |
| 2013 Q4 | -140.12 Million HKD | 8.56% |
| 2013 FY | -140.12 Million HKD | 57.97% |
| 2013 Q1 | -333.38 Million HKD | -4.74% |
| 2013 Q2 | -153.23 Million HKD | 54.04% |
| 2012 FY | -333.38 Million HKD | -109.68% |
| 2012 Q2 | -231.75 Million HKD | -45.76% |
| 2012 Q1 | -158.99 Million HKD | 0.0% |
| 2012 Q3 | -217.57 Million HKD | 6.12% |
| 2012 Q4 | -318.3 Million HKD | -46.3% |
| 2011 FY | -158.99 Million HKD | 28.47% |
| 2011 Q3 | -187.44 Million HKD | 0.0% |
| 2011 Q1 | -222.26 Million HKD | 0.0% |
| 2010 Q3 | -309.82 Million HKD | 0.0% |
| 2010 Q1 | -344.22 Million HKD | 0.0% |
| 2010 FY | -222.26 Million HKD | 35.43% |
| 2009 FY | -344.22 Million HKD | -364.76% |
| 2008 FY | -74.06 Million HKD | -111.01% |
| 2007 FY | 672.43 Million HKD | 9.9% |
| 2006 FY | 611.86 Million HKD | 10.62% |
| 2005 FY | 553.12 Million HKD | 9.62% |
| 2004 FY | 504.59 Million HKD | 8.58% |
| 2003 FY | 464.73 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 27.54 Million HKD | -3219.685% |
| China Overseas Nuoxin International Holdings Limited | 9.99 Million HKD | -9051.977% |
| Prosperous Future Holdings Limited | -337.41 Million HKD | 370.993% |
| Huasheng International Holding Limited | 175.03 Million HKD | -422.389% |
| Fourace Industries Group Holdings Limited | -250.33 Million HKD | 465.263% |
| Evergreen Products Group Limited | 430.83 Million HKD | -112.233% |
| EC Healthcare | 1.05 Billion HKD | 12.923% |
| Ming Fai International Holdings Limited | -329.49 Million HKD | 377.512% |
| Blue Moon Group Holdings Limited | -4.18 Billion HKD | 121.856% |
| SuperRobotics Holdings Limited | 126.44 Million HKD | -623.163% |
| Takbo Group Holdings Limited | -175.44 Million HKD | 621.189% |
| Hyfusin Group Holdings Limited | -318.4 Million HKD | 387.17% |